{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:54:01Z","timestamp":1790477641859,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005072","name":"Japanese Pulmonary Circulation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15K09116"],"award-info":[{"award-number":["15K09116"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24591032"],"award-info":[{"award-number":["24591032"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ijcard.2019.11.139","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:38:56Z","timestamp":1574854736000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan"],"prefix":"10.1016","volume":"300","author":[{"given":"Katsuya","family":"Kozu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.11.139_bb0005","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","volume":"40","author":"Voelkel","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0015","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000370125","article-title":"Long-term data from the Swiss pulmonary hypertension registry","volume":"89","author":"Mueller-Mottet","year":"2015","journal-title":"Respiration."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0035","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0040","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0050","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-year outcomes of patients enrolled in the REVEAL Registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"Survival in pulmonary hypertension in Spain: insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0070","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ijcard.2015.11.039","article-title":"Management and outcomes in chronic thromboembolic pulmonary hypertension: from expert centers to a nationwide perspective","volume":"203","author":"Escribano-Subias","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0080","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0085","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1253\/circj.CJ-17-0139","article-title":"Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension","volume":"82","author":"Tamura","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0105","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0110","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2188\/jea.JE20100180","article-title":"Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies","volume":"21","author":"Sasazuki","year":"2011","journal-title":"J Epidemiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0130","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2013.06.046","article-title":"Relationships between right ventricular function, body composition, and prognosis in advanced heart failure","volume":"62","author":"Melenovsky","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2015.03.354","article-title":"Relationships between nutritional status and markers of congestion in patients with pulmonary arterial hypertension","volume":"187","author":"Kawamoto","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.healun.2017.10.028","article-title":"Impact of declining renal function on outcomes in pulmonary arterial hypertension: a REVEAL registry analysis","volume":"37","author":"Chakinala","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0145","doi-asserted-by":"crossref","unstructured":"Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur. Heart J. 2014;35:455\u201369.","DOI":"10.1093\/eurheartj\/eht386"},{"key":"10.1016\/j.ijcard.2019.11.139_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2016.07.001","article-title":"Epidemiology of pulmonary hypertension in left heart disease","volume":"59","author":"Guha","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0155","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi","year":"2012","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1253\/circj.CJ-11-1217","article-title":"Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension","volume":"76","author":"Sugimura","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0165","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcin.2013.03.009","article-title":"Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty","volume":"6","author":"Inami","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0170","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1183\/09031936.00012914","article-title":"Right ventricular reverse remodelling after balloon pulmonary angioplasty","volume":"43","author":"Fukui","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0175","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4244\/EIJV10I4A89","article-title":"Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension","volume":"10","author":"Taniguchi","year":"2014","journal-title":"EuroIntervention."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0180","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/eurheartj\/ehx530","article-title":"Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications","volume":"38","author":"Aoki","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2014.05.011","article-title":"Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients","volume":"175","author":"Yanagisawa","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2015.10.030","article-title":"Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"35","author":"Wiedenroth","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2009.07.015","article-title":"A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension","volume":"104","author":"Mubarak","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China","volume":"236","author":"Zhao","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0210","doi-asserted-by":"crossref","unstructured":"Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457\u201362; discussion 62\u20134.","DOI":"10.1016\/S0003-4975(03)00828-2"},{"key":"10.1016\/j.ijcard.2019.11.139_bb0215","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.athoracsur.2006.03.121","article-title":"Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension","volume":"82","author":"Ogino","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0220","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1183\/13993003.00364-2015","article-title":"Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN","volume":"46","author":"Simonneau","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0230","doi-asserted-by":"crossref","unstructured":"Forfia PR, Borlaug BA. Letter by Forfia and Borlaug regarding article, \u201cPulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study\u201d. Circulation. 2012;125:e408; author reply e9\u201310.","DOI":"10.1161\/CIRCULATIONAHA.111.064584"},{"key":"10.1016\/j.ijcard.2019.11.139_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/resp.12530","article-title":"Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases","volume":"20","author":"Tanabe","year":"2015","journal-title":"Respirology."},{"key":"10.1016\/j.ijcard.2019.11.139_bb0240","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/688712","article-title":"The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study","volume":"6","author":"Sato","year":"2016","journal-title":"Pulm Circ."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319321461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319321461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:45:40Z","timestamp":1759092340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319321461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":48,"alternative-id":["S0167527319321461"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.139","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}